Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.

Topics

Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy

Zepbound helped patients lose more weight than a major rival in a head-to-head trial.
MarketWatch - 7h
Zepbound brings more weight loss than Wegovy: Drugmaker

Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from their ...
The Hill - 3h
A rival weight loss drug to Wegovy helped people shed more pounds, study shows

People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.
NBC News - 8h
Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

New trial data has cemented Club holding Eli Lilly's pole position in the highly competitive weight loss drug race.
CNBC - 3h
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance

The health care giant’s David Ricks defended the agency’s role in reviewing data and ensuring drug safety.
The New York Times - 1h
Experts create controllable gastric balloon to aid weight loss

Device inflates before eating and contracts afterwards, simulating the effects of having a meal, say scientists. From weight loss jabs to vibrating pills , the obesity crisis has spawned myriad ...
The Guardian - 1d
Will Trump nix Biden’s coverage plan for weight-loss drugs? It’ll be a close call.

While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says it’s possible he could end up supporting the Democratic incumbent’s ...
MarketWatch - 2h

Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

Topics

Related

Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy

Zepbound brings more weight loss than Wegovy: Drugmaker

A rival weight loss drug to Wegovy helped people shed more pounds, study shows

Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance

Experts create controllable gastric balloon to aid weight loss

Will Trump nix Biden’s coverage plan for weight-loss drugs? It’ll be a close call.

More from CNBC

Jeff Bezos says he's optimistic about Trump, will help with reducing regulation

Powell says he's not worried about the Fed losing its independence under Trump

UnitedHealthcare CEO Brian Thompson fatally shot in New York in targeted attack

French government toppled in no-confidence vote brought by opposition

Shares of American Eagle plunge 13% as company issues weak holiday guidance